Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 3,979 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Preclinical Alzheimer's Disease, Alzheimer Disease, Prodromal Alzheimer's Disease
Interventions: AADvac1, Tau2; Drug
Lead sponsor: Paul S. Aisen; Other
Eligibility: 50 Years to 80 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 7
States / cities: Phoenix, Arizona • San Francisco, California • Lexington, Kentucky + 4 more

Conditions: Mild Cognitive Impairment
Interventions: PRISEM Remote; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 50 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Mild Cognitive Impairment
Interventions: Auditory stimulation during sleep, Sham Intervention; Other
Lead sponsor: Northwestern University; Other
Eligibility: 60 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: BPH, Lower Urinary Tract Symptoms
Interventions: Telephone Interview, Questionnaires over the span of 24 months; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Binge Eating, Binge-Eating Disorder, Bulimia Nervosa
Interventions: Group Reward Retraining; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mild Cognitive Impairment
Interventions: VR cognitive training platform; Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Age-Associated Memory Impairment
Interventions: Tricaprilin, Placebo; Drug · Other
Lead sponsor: Cerecin; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 6
States / cities: Brooksville, Florida • DeLand, Florida • Naples, Florida + 3 more

Conditions: Insomnia, Sleep Initiation and Maintenance Disorders, Alzheimer Disease
Interventions: modafinil; Drug
Lead sponsor: VA Palo Alto Health Care System; Federal
Eligibility: 50 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Delirium
Interventions: Family Support System, HELP Support System; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 70 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cancer Survivor, Stage I Rectosigmoid Cancer, Stage II Rectosigmoid Cancer, Stage III Rectosigmoid Cancer
Interventions: Informational Intervention, Quality-of-Life Assessment, Questionnaire Administration, Survey Administration, Telephone-Based Intervention; Other · Behavioral
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Tucson, Arizona • Duarte, California

Conditions: Cognitive Impairment, Vascular Diseases, Alzheimer Disease, Atherosclerosis
Interventions: 11C-PIB; Drug
Lead sponsor: José A. Luchsinger; Other
Eligibility: 60 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-alcoholic Fatty Liver Disease
Interventions: Efimosfermin alfa; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 5
States / cities: Rialto, California • Miami Lakes, Florida • Tampa, Florida + 2 more

Conditions: Otitis Media, Serous, Negative Middle Ear Pressure, Rhinitis, Otitis Media With Effusion, Otitis Media, Secretory
Interventions: Triamcinolone acetonide nasal spray, Placebo nasal spray; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 6 Years to 100 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Alzheimer Disease, Dementia, Cognitive Dysfunction
Interventions: Not listed
Lead sponsor: Anne Murray; Other
Eligibility: 65 Years and older
Enrollment: 13,435 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 4
States / cities: Decatur, Georgia • Minneapolis, Minnesota • Winston-Salem, North Carolina

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Lighting Intervention; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Albany, New York • New York, New York

Conditions: Erectile Dysfunction
Interventions: Utilization of Serenita for Relaxation; Behavioral
Lead sponsor: Eco Fusion; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer Disease, Cognitive Impairment
Interventions: Caregiver vs. Patient [Beginner], Caregiver vs. Caregiver, Caregiver vs. Physician, Caregiver vs. Patient [Advanced]; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years and older
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Health, Subjective, Gastrointestinal Dysfunction, Cardiovascular Risk Factor, Autoimmune Diseases, Dental Diseases, Hormone Disturbance, Neurocognitive Dysfunction
Interventions: Not listed
Lead sponsor: Metagenics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Gig Harbor, Washington

Conditions: Hepatitis C
Interventions: DCV 3DAA FDC, BMS-791325; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 4
States / cities: Miami, Florida • Orlando, Florida • Minneapolis, Minnesota + 1 more

Conditions: Sickle Cell Disease, Cognitive Impairment, Adolescent Behavior, Self Efficacy, Health-Related Behavior, Coping Skills
Interventions: CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 10 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Heart Failure
Interventions: Nicotinamide Riboside; Dietary Supplement
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy
Interventions: BioDFence G3 Placental Tissue Membrane, Robot-Assisted Radical Prostatectomy; Biological · Procedure
Lead sponsor: University of Miami; Other
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Mild Cognitive Impairment, Cognitive Impairment
Interventions: 20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company), 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company); Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years to 85 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Lymphoma, Autonomic Imbalance, Cancer Survivorship
Interventions: Ivabradine, Placebo Oral Tablet; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Boston, Massachusetts

Search by objective public record fields.

Alzheimer's Tau Platform: Master Protocol

PRogram to Improve Stress-levels and Enhance Memory

Auditory Stimulation of Slow Wave Sleep and Memory in Mild Cognitive Impairment and Older Adults

HoLEP Sexual Survivorship

Development and Initial Tests of Reward Re-Training: A Novel Treatment For Reward Dysfunction

A Health Game Intervention for Cancer and Post-ICU Patients Suffering From Acute Cognitive Impairment

Tricaprilin In Age-Associated Memory Impairment

Modafinil Treatment for Sleep/Wake Disturbances in Older Adults

Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

11C-PIB PET Study in MESA at Columbia University

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays

Sex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias

The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment

Stress Management Using an App to Improve Response With PDE5 Inhibitors in Men With Erectile Dysfunction.

Negotiation Training for Caregiver Communication in AD

Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC)

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

Cognitive Remediation Intervention to Prepare for Transition of Care

The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects

Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy

SNIFF Multi-Device Study 2

Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.